IBD is likely over-diagnosed and steroids are often started too quickly.

IBD is likely over-diagnosed and steroids are often started too quickly.

• A. True
• B. False
• C. Sometimes true
• D. Cannot determine

Answer: (A)

Diagnosing inflammatory bowel disease can be challenging because its symptoms overlap with many other conditions, including irritable bowel syndrome, infections, and other inflammatory disorders. Because of this overlap, IBD is sometimes labeled based on symptoms or non-specific tests rather than on definitive evidence from endoscopy and histology, leading to over-diagnosis. At the same time, steroids can produce rapid relief of symptoms and are often used to control inflammation quickly, so in some cases they’re started before a firm, objective diagnosis is established. While steroids have a role in induction therapy for confirmed moderate-to-severe disease, using them before confirming the diagnosis can mask the true underlying condition, delay appropriate treatment, and expose patients to unnecessary steroid side effects. Therefore, the statement reflects real clinical concerns: IBD can be over-diagnosed, and steroids are sometimes started too quickly. The ideal approach is to confirm the diagnosis with endoscopy and biopsy (and use noninvasive markers like fecal calprotectin to guide decisions) and to reserve steroid use for appropriately confirmed cases while remaining vigilant for other causes such as infectious colitis.

Diagnosing inflammatory bowel disease can be challenging because its symptoms overlap with many other conditions, including irritable bowel syndrome, infections, and other inflammatory disorders. Because of this overlap, IBD is sometimes labeled based on symptoms or non-specific tests rather than on definitive evidence from endoscopy and histology, leading to over-diagnosis. At the same time, steroids can produce rapid relief of symptoms and are often used to control inflammation quickly, so in some cases they’re started before a firm, objective diagnosis is established. While steroids have a role in induction therapy for confirmed moderate-to-severe disease, using them before confirming the diagnosis can mask the true underlying condition, delay appropriate treatment, and expose patients to unnecessary steroid side effects. Therefore, the statement reflects real clinical concerns: IBD can be over-diagnosed, and steroids are sometimes started too quickly. The ideal approach is to confirm the diagnosis with endoscopy and biopsy (and use noninvasive markers like fecal calprotectin to guide decisions) and to reserve steroid use for appropriately confirmed cases while remaining vigilant for other causes such as infectious colitis.